Okabena Investment Services Inc Abb Vie Inc. Transaction History

Okabena Investment Services Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $24,981 - $28,919	-187 Reduced 90.78%	19 $2,000
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $24,779 - $30,836	187 Added 984.21%	206 $27,000
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $86,766 - $99,924	-600 Reduced 96.93%	19 $3,000
Q4 2022 Feb 08, 2023	BUY	$138.31 - $165.87 $2,627 - $3,151	19 Added 3.17%	619 $100,000
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $82,572 - $104,976	600 New	600 $92,000
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $55,111 - $69,732	-513 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $53,972 - $60,128	513 New	513 $58,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Okabena Investment Services Inc, based on Form 13F filings with the SEC.

Stay updated on Okabena Investment Services Inc with notifications on news.